Anti-Cytokeratin 20 antibody [Ks20.8]
4
(4 Reviews)
|
(13 Publications)
Mouse Monoclonal Cytokeratin 20 antibody. Suitable for Flow Cyt, ICC/IF, IHC-P and reacts with Human samples. Cited in 13 publications.
View Alternative Names
Cytokeratin-20, Keratin-20, Protein IT, CK-20, K20, KRT20
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 20 antibody [Ks20.8] (AB854)
ICC/IF image of ab854 stained Jeg3 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab854, 1/200 dilution) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 20 antibody [Ks20.8] (AB854)
ab854 staining cytokeratin in human colon cancer tissue section by Immunohistochemistry (Formalin/ PFA fixed paraffin embedded tissue sections).
- Flow Cyt
Unknown
Flow Cytometry - Anti-Cytokeratin 20 antibody [Ks20.8] (AB854)
Overlay histogram showing LoVo cells stained with ab854 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab854, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 20 antibody [Ks20.8] (AB854)
Immunofluorescent analysis of human colon epithelium, staining Cytokeratin 20 with ab854.
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cytokeratin 20 is essential in cellular differentiation and maintenance within epithelial tissues. It plays an important role in the structural framework of epithelial cells by integrating into the cytoskeletal network which includes other keratins. Typically cytokeratin 20 forms heterodimers with keratin 8 contributing to the assembly of intermediate filaments. These interactions maintain cell stability and are involved in cellular processes such as migration and proliferation.
Pathways
Cytokeratin 20 participates in the framework of intermediate filament signaling influencing cell motility and secretion in epithelial tissues. It contributes mainly to the keratinization pathway which is critical in forming a protective barrier in epithelial cells. Additionally it is related to cell adhesion and signalling pathways that are important for tissue integrity. Connections with keratin 8 and other cytoskeletal proteins facilitate signal transduction processes necessary for epithelial homeostasis and response to injury.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Oncogene 44:3924-3938 PubMed40851030
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of surgical oncology 32:7333-7343 PubMed40745121
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:420 PubMed40436833
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ systems biology and applications 11:12 PubMed39875420
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:878 PubMed39632825
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 58:e13757 PubMed39329245
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature microbiology 8:875-888 PubMed37037942
2023
Applications
Unspecified application
Species
Unspecified reactive species
eNeuro 9: PubMed36635242
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 23:9 PubMed34820008
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of comparative neurology 529:3046-3061 PubMed33786834
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com